Editas Medicine | DEFA14A: Others
Editas Medicine | DEF 14A: Definitive information statements
Editas Medicine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(10.71%),SSGA FUNDS MANAGEMENT, INC.(8.50%)
Editas Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Lucera Erick
Editas Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Burkly Linda
Editas Medicine | 4: Statement of changes in beneficial ownership of securities-Officer O'Neill Gilmore Neil
Editas Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Mei Baisong
Editas Medicine | 144: Notice of proposed sale of securities pursuant to Rule 144
Editas Medicine | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Editas Medicine | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Editas Medicine | 10-K: Annual report
Editas Medicine | 8-K: Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
Editas Medicine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(6.70%),Deep Track Biotechnology Master Fund, Ltd.(6.70%), etc.
Editas Medicine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(10.36%)
Editas Medicine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(9.6%)
Editas Medicine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(6.21%)
Editas Medicine | 8-K: Current report
Editas Medicine | 8-K: Current report
Editas Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Eaton Bruce
Editas Medicine | 8-K: Current report
No Data